The Cole Center for Healing

04/01/2026

'm thinking of producing some educational courses on medical topics. What are the main topics you would like to see covered?

Call now to connect with business.

04/01/2026

I get questions about the shingles vaccine, so here's info from the studies: Only 3.5 out of 100 unvaccinated people in this age group developed shingles over roughly three years. That means 96.5 out of 100 would not have gotten shingles anyway, with or without the vaccine.

“97% effective” means the vaccine reduced the rate among those who would have gotten shingles. It does not mean 97 in 100 vaccinated people are protected from something that would otherwise have happened to them.

The absolute benefit, the actual reduction in cases attributable to vaccination, was about 3.4 cases prevented per 100 people vaccinated over three years. That translates to a “number needed to treat” (NNT) of approximately 30 people you need to vaccinate in this age group to prevent one case of shingles over a three-year period.

In the trials, 78 to 84 percent of vaccinated people reported at least one reaction within 7 days, compared with about 30 percent in the placebo group. Most were mild: sore arm, tiredness, headache. But a meaningful proportion were severe enough to disrupt daily life. This is measured as “grade 3” reactions — fever over 39°C, muscle pain that prevents normal activity, and injection-site pain at rest.

The “number needed to harm” (NNH) for a grade 3 reaction, meaning one serious enough to stop you doing normal things for a day or two, was:

• Ages 50–69: approximately 1 in 11 vaccinated people

• Ages 70+: approximately 1 in 25 vaccinated people

All of the clinical evidence for Shingrix, every pivotal trial, every extension study, every long-term follow-up analysis, was funded by GlaxoSmithKline, the vaccine’s manufacturer. Several named authors on the key publications were GSK employees at the time. Medical writing for the main publications was paid for by GSK. The decision about when to submit results for publication was made by GSK.

For the full description, go here:

The headline number is 97% effective. The number that actually matters to you is closer to 3%. Both are true. Here's what's going on — and why the distinction matters.

03/31/2026

The Cole Center for Healing is a family, practice, specializing and holistic/integrative medicine. If you have been struggling with health issues that you can’t seem to find the answer to or just want to improve your health we can help! In our practice we see patients from all over the world for things from newborn baby check ups to stage four cancer

03/20/2026

More Covid vaccine news: A growing body of peer-reviewed research published between 2023 and 2025 documents that repeated mRNA boosting causes a progressive shift in the type of antibody your immune system produces against the virus. This shift is not random noise. It follows a well-understood biological pattern. And it has measurable, functional consequences.

1. Increased risk of breakthrough COVID infection

Martín Pérez et al. (2025) found that healthcare workers who developed the IgG4 shift were more likely to get COVID afterward. This is the first published study to link the antibody shift to an actual adverse health outcome. It needs replication, but the direction is predicted by the biology.

2. Loss of the immune functions that clear infected cells

Kalkeri et al. (2025) directly measured the functional consequences. Higher IgG4 was correlated with reduced capacity for three distinct immune clearance mechanisms: ADCC (r = –0.53), complement deposition (r = –0.53), and phagocytosis (r = –0.40). These are not theories. They are published measurements.

3. The damage is written into immune memory

Irrgang et al. (Science Immunology, 2023) found that 14.4% of the long-term immune memory cells targeting the spike protein were IgG4-producing after repeated boosting. These cells persist for years. The impairment does not fade when vaccination stops.

4. Children are also affected

Kobbe et al. (Pediatric Infectious Disease Journal, 2024) confirmed IgG4 switching in children aged 5 to 11 after only two standard pediatric doses. The effect is not limited to adults who received many boosters.

For the complete explanation, go to:

A plain-language guide to what the research now shows

03/06/2026

This is one of the scariest studies I've seen lately:

Elevated residential extremely low-frequency magnetic fields (ELF-MF) exposure, as well as prolonged tablet use, both with and without internet connectivity, were significantly associated with an increased risk of developing Central nervous system tumors (CNST) in childhood.

Sources include cell phones, towers, etc. Since everyone is exposed to these fields, I've looked for a way to minimize their effect. The only one I've found in the last several years that is reliable is by Aires. If you'd like more info or evaluation, call us at 513-563-4321. To order, go to: airestech.com/?utm_source=theodore-cole-60160&utm_medium=Ambassador60160&utm_

Víctor Correa‐Correa, et. al. Extremely low-frequency magnetic fields (ELF-MF) and radiofrequency: Risk of childhood CNS tumors in a city with elevated ELF-MF exposure,
Environmental Research, Volume 286, Part 2, 2025, 122858,
ISSN 0013-9351,
https://doi.org/10.1016/j.envres.2025.122858.

Explore Aires Tech's advanced EMF protectors for your cell phone and digital lifestyle. Shield against EMF radiation! Better than an EMF blocker.

03/06/2026

03/04/2026

This might help explain why I find so many cases of Lyme:

An extensive investigation based on declassified government documents and previously suppressed scientific research has uncovered compelling evidence that U.S. biological weapons programs contributed to the emergence of Lyme disease, which now affects hundreds of thousands of Americans annually.

The investigation reveals a pattern of concealment spanning six decades, including the systematic suppression of critical medical research and the release of nearly 300,000 radioactive ticks across Virginia to study how the disease-carrying insects would spread.

Between 1966 and 1969, the U.S. military released 282,800 lone star ticks made radioactive with Carbon-14 across Virginia sites along bird migration routes. The radioactive marking allowed researchers to track the ticks’ spread using Geiger counters over several years.

Before these experiments, lone star ticks were not found above the Mason-Dixon Line. Within years of the Virginia releases, they had established populations on Long Island for the first time. Two tick experts consulted about these releases said they “were aghast” and “you’d never be able to do that now.”

Read the entire article here:

Exclusive: Military released 282,800 radioactive ticks, suppressed co-infection research for 40 years

03/01/2026

Yep, shedding is a real thing:

Indirect exposure to COVID-19 vaccinated persons was significantly associated with the likelihood of the onset of menstrual irregularities. This study provides additional data to complement a growing body of evidence raising concerns regarding the safety of mRNA vaccines.

This article will map out everything that is known about shedding (e.g., what are the common symptoms, how does it happen, who does it affect, does it occur through sexual contact, can it cause severe issues like cancer) along with strategies for preventing it.

Sue E. Peters, et. al. Menstrual Abnormalities Strongly Associated with Proximity to COVID-19 Vaccinated Individuals. International Journal of Vaccine Theory, Practice, and Research, Vol. 3 No. 2 (2024): Injuries, Causes, and Treatments, Part 2.
DOI:

Menstrual Abnormalities Strongly Associated with Proximity to COVID-19 Vaccinated Individuals Authors Sue E. Peters† Independent Researcher, New York, NY Jill Newman† Independent Researcher, Mount Pleasant, SC Heather Ray Science and Research Assistant, Children’s Health Defense, Franklin Lake...

02/28/2026

This changes things: We’ve long been told that positive visualization can make things more likely to happen. But that’s not actually the case, according to Gabriele Oettingen, Ph.D., professor of psychology at New York University. In fact, that approach can backfire. Pure positive visualization can make our brain think we’ve already accomplished our goal, leaving us ill-equipped to handle obstacles and setbacks along the way.

Oettingen recommends “mental contrasting” to move those dreams into actual results. The practice includes both contrasting parts in the visualization.

Oettingen developed a simple plan called WOOP, which stands for Wish, Outcome, Obstacle, Plan. Write down your wish (a goal that’s feasible). Next, imagine the best outcomes that can occur if that wish comes to pass. After that, list any potential obstacles you could encounter. Last, make an “if-then” plan for each one: “If [X obstacle] occurs, I will do [Y action].”

Call now to connect with business.

02/22/2026

For all of those taking GLP-1 agents:

In the Butsch et al study of 461,382 GLP-1 users, 12.7% were newly diagnosed with a nutritional deficiency at 6 months, most commonly vitamin D deficiency (7.5%). This lack of vitamin D increased to 13.6% of GLP-1 users at 12 months. Diagnoses of muscle loss, B vitamin deficiencies, dehydration, and mineral deficiencies (calcium, selenium, and zinc) also rose over time.

In another study involving 18,746 adults with T2D, GLP-1 users had a 49% higher risk for vitamin D deficiency than SGLT2 inhibitor users, a 32% higher risk for vitamin D deficiency than DPP-4 inhibitor users, and a 54% higher risk for lower levels of ferritin (iron) than SGLT2 inhibitor users.

A prospective pilot study of 51 adults with T2D showed markedly reduced intestinal iron absorption after 10 weeks of semaglutide therapy.

A register-based cohort study involving 439 patients with T2D and hereditary hemochromatosis showed that GLP-1 users also had 26%-30% lower ferritin levels than SGLT2 inhibitor users.
In a dietary analysis of 69 GLP-1 users, most failed to meet recommended intakes for vitamin D, iron, calcium, and protein; separate case reports linked GLP-1 use to severe thiamine deficiency, including cases of Wernicke encephalopathy and beriberi.

If you are taking any GLP-1, I suggest both blood work and a Tissue Mineral Analysis to make sure you're nutritional levels are optimal. Call us at 513-563-4321 to set up an appointment.

J. Urbina, L. E. Salinas-Ruiz, C. Valenciano, and B. Clapp, “ Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrative Review,” Clinical Obesity 16, no. 1 (2026): e70070, https://doi.org/10.1111/cob.70070.

Call now to connect with business.

02/20/2026

More bad news about the Covid vaccines: this study found that excess mortality is due to the COVID-19 vaccination program, and by explaining that governments already admit to COVID-19 vaccine deaths, and also ruling out the typical alternative explanations of COVID-19 itself and the lockdowns.

From the study: Conclusions
Combined with increasing evidence that the efficacy/effectiveness and safety of COVID-19 vaccines have been greatly exaggerated, including acknowledgements from the Australian and American governments that several deaths have been caused by the vaccines, these findings make it a near-certainty that COVID-19 vaccines have been – and continue to be – contributing to excess mortality.

Lataster R. The causes of Australian excess deaths in 2021, and beyond: An ecological study considering COVID-19, the lockdowns, and the vaccines. International Journal of Risk & Safety in Medicine. 2026;0(0). doi:10.1177/09246479261426743

Call now to connect with business.